Published in Proc R Soc Med on January 01, 1977
Cephalosporinase and penicillinase activities of a beta-lactamase from Pseudomonas pyocyanea. Biochem J (1965) 12.54
Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma. J Lab Clin Med (1971) 8.13
Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins. Antimicrob Agents Chemother (1975) 6.82
Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics. Antimicrob Agents Chemother (1976) 3.59
Independent measurement of ampicillin and cloxacillin in mixtures. Appl Microbiol (1967) 1.12
Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother (1975) 17.12
Cephalosporinase and penicillinase activities of a beta-lactamase from Pseudomonas pyocyanea. Biochem J (1965) 12.54
A new type of penicillin resistance of Staphylococcus aureus. Lancet (1977) 9.15
Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma. J Lab Clin Med (1971) 8.13
Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins. Antimicrob Agents Chemother (1975) 6.82
Suppression of intrinsic resistance to methicillin and other penicillins in Staphylococcus aureus. Antimicrob Agents Chemother (1972) 3.88
Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin Infect Dis (2004) 3.69
Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics. Antimicrob Agents Chemother (1976) 3.59
Chemical and physical factors influencing methicillin resistance of Staphylococcus aureus and Staphylococcus epidermidis. J Antimicrob Chemother (1977) 3.56
Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. JAMA (1978) 3.13
Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro. Antimicrob Agents Chemother (1973) 3.05
The problems of drug-resistant pathogenic bacteria. Factors influencing methicillin resistance in staphylococci. Ann N Y Acad Sci (1971) 2.96
Effect of protein A on staphylococcal opsonization. Infect Immun (1977) 2.79
Effect of pH on the activity of erythromycin against 500 isolates of gram-negative bacilli. Appl Microbiol (1970) 2.75
Rapid microassay for circulating nephrotoxic antibiotics. Antimicrob Agents Chemother (Bethesda) (1970) 2.73
Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains. Immunology (1977) 2.73
Synergy of antibacterial substances by apparently known mechanisms. Antimicrob Agents Chemother (Bethesda) (1967) 2.56
Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria. Appl Microbiol (1968) 2.55
Synergistic combinations of penicillins in the treatment of bacteriuria. N Engl J Med (1967) 2.53
Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization. J Lab Clin Med (1968) 2.45
In vitro activity of cephalosporins against methicillin-resistant, coagulase-negative staphylococci. J Infect Dis (1978) 2.39
Thiol-group binding of zinc to a beta-lactamase of Bacillus cereus: differential effects on enzyme activity with penicillin and cephalosporins as substrates. J Bacteriol (1968) 2.08
Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus. Ann Intern Med (1982) 2.05
Rapid microassays for clindamycin and gentamicin when present together and the effect of pH and of each on the antibacterial activity of the other. Antimicrob Agents Chemother (1974) 1.92
Resistance of penicillins and cephalosporins to beta-lactamases from Gram-negative bacilli: some correlations with antibacterial activity. Ann N Y Acad Sci (1967) 1.88
Outbreak of central-nervous-system toxoplasmosis in western Europe and North America. Lancet (1983) 1.80
Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistance. Diagn Microbiol Infect Dis (1992) 1.74
Zinc as a cofactor for cephalosporinase from Bacillus cereus 569. Biochem J (1966) 1.74
The assay of antimicrobial compounds. Hum Pathol (1976) 1.69
Cephalosporinase and penicillinase activity of Bacillus cereus. Antimicrob Agents Chemother (Bethesda) (1965) 1.68
Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents. Antimicrob Agents Chemother (1976) 1.65
Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes. Infect Immun (1976) 1.63
Independent segregation of chloramphenicol resistance in Staphylococcus aureus. Antimicrob Agents Chemother (Bethesda) (1967) 1.63
Transplacental passage of erythromycin and clindamycin. N Engl J Med (1973) 1.59
Use of a heavy inoculum in the in vitro evaluation of the anti-staphylococcal activity of 19 cephalosporins. Antimicrob Agents Chemother (1978) 1.57
Discriminant analysis of congenital esotropia surgery. Predictor variables for short- and long-term outcomes. Ophthalmology (1983) 1.52
Cell wall composition and associated properties of methicillin-resistant Staphylococcus aureus strains. J Bacteriol (1978) 1.51
Susceptibility of pneumococci and Haemophilus influenzae to antibacterial agents. Antimicrob Agents Chemother (1976) 1.49
Synergistic penicillin combinations for treatment of human urinary-tract infections. Antimicrob Agents Chemother (Bethesda) (1966) 1.48
Diabetes mellitus and intraocular lens implantation. Ophthalmology (1983) 1.47
Antagonism of the antibacterial action of some penicillins by other penicillins and cephalosporins. J Clin Invest (1975) 1.45
Severe bronchospasm followed by respiratory arrest during thallium-dipyridamole imaging. Chest (1989) 1.45
Penicillins and cephalosporins: differences in morphologic effects on Proteus mirabilis. J Infect Dis (1972) 1.45
In vitro activity of cefazolin against recent clinical bacterial isolates. J Infect Dis (1973) 1.42
Altered cell walls of Staphylococcus aureus resistant to methicillin. Nature (1970) 1.39
What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria? Bone Marrow Transplant (2006) 1.39
Increasing the usefulness of antibiotics: Treatment of infections caused by gram-negative bacilli. Clin Pharmacol Ther (1970) 1.38
Isolation of Chlamydia trachomatis from the lower respiratory tract of adults. Lancet (1980) 1.37
Rapid semiquantitative testing of antibiotic susceptibility: use of a multicell disk elution system. Antimicrob Agents Chemother (1975) 1.28
Methicillin resistance of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother (Bethesda) (1968) 1.28
Resistance of Staphylococcus aureus to penicillins and cephalosporins: reversal of intrinsic resistance with some chelating agents. Ann N Y Acad Sci (1974) 1.25
Erythromycin and alkalinisation of urine in the treatment of urinary-tract infections due to gram-negative bacilli. Lancet (1971) 1.18
Measurement of three antibiotics (penicillin, cephalothin, and chloramphenicol) when present together in mixtures. Appl Microbiol (1968) 1.18
Serum glutamic oxalacetic transaminase. False elevations during administration of erythromycin. N Engl J Med (1968) 1.17
Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clin Infect Dis (1999) 1.17
Concentration of antifungal agents within host cell membranes: a new paradigm governing the efficacy of prophylaxis. Antimicrob Agents Chemother (2011) 1.15
Independent measurement of ampicillin and cloxacillin in mixtures. Appl Microbiol (1967) 1.12
Antibiotic resistance. Epidemiology and therapeutics. Diagn Microbiol Infect Dis (1992) 1.09
A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry (1990) 1.09
Susceptibility of Neisseria gonorrhoeae to 66 antibacterial agents in vitro. J Am Vener Dis Assoc (1976) 1.08
A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies. Clin Infect Dis (2006) 1.04
Parenteral clindamycin phosphate: pharmacology with normal and abnormal liver function and effect on nasal staphylococci. Antimicrob Agents Chemother (1975) 1.03
Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med (1993) 1.02
Anti-staphylococcal activity of a penem, Sch 29482. J Antimicrob Chemother (1982) 1.01
Endocarditis caused by coagulase-negative staphylococci. Infection (1979) 0.99
In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centers. Eur J Epidemiol (1993) 0.99
The effect of some penicillins on Mycobacterium tuberculosis. Am Rev Respir Dis (1972) 0.99
Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin. Chemotherapy (1985) 0.98
Salmonellosis and shigellosis at Boston City Hospital. 2. Susceptibility of strains of Salmonellae and Shigellae to antibacterial agents. JAMA (1974) 0.98
Sequence effect on ampicillin blood levels noted in an amoxicillin, ampicillin, and epicillin triple crossover study. Antimicrob Agents Chemother (1975) 0.95
Decrease in ribosomal density of Proteus mirabilis exposed to subinhibitory concentrations of ampicillin or cephalothin. Proc Soc Exp Biol Med (1975) 0.95
Dengue hemorrhagic fever in North America: a case report. Pediatrics (1980) 0.92
Drug resistance of bacteria. N Engl J Med (1969) 0.92
Antibiotic sensitivity and synergism of 'penicillin-tolerant' Staphylococcus aureus. Chemotherapy (1979) 0.91
Thorn-induced periostitis associated with Enterobacter agglomerans infection. Can Med Assoc J (1978) 0.88
Tissue penetration of antibiotics; an overview. Scand J Infect Dis Suppl (1978) 0.87
Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics. J Infect Dis (1976) 0.87
Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group. Am Surg (1993) 0.86
Comparative activity of trovafloxacin and Bay 12-8039 against 452 clinical isolates of Streptococcus pneumoniae. J Antimicrob Chemother (1998) 0.85
Susceptibility of Diplococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis to 23 antibiotics. Antimicrob Agents Chemother (Bethesda) (1970) 0.83
Brain abscess due to Petriellidium boydii. Can J Neurol Sci (1984) 0.83
The outlook for prevention and treatment of infections due to Pseudomonas aeruginosa. Rev Infect Dis (1987) 0.82
Erythromycin and clindamycin absorption and elimination in pregnant women. Clin Pharmacol Ther (1976) 0.81
Biochemical and physiologic basis for susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents. Rev Infect Dis (1987) 0.80
Study of the comparative activity of piperacillin/tazobactam with currently available antibiotics against 8206 aerobic isolates. Can J Infect Dis (1997) 0.80
Enhanced activity of novobiocin against gram-negative bacilli in acid media. Antimicrob Agents Chemother (Bethesda) (1968) 0.80
Phenoxymethylpenicillin (penicillin V) and phenethicillin. Med Clin North Am (1970) 0.80
Adding 2% glucose to culture media does not influence the activity of caspofungin against Candida species. J Antimicrob Chemother (2003) 0.80
Effect of amphetamine on the swimming endurance of rats. Neuropharmacology (1973) 0.79
Length-tension properties of extraocular muscles in patients with esotropia and intermittent exotropia. Am J Ophthalmol (1994) 0.78
Cell walls of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (Bethesda) (1969) 0.78
Peritonitis due to Mycoplasma hominis in a renal transplant recipient. J Infect Dis (1982) 0.78
Penetration of aztreonam into human cerebrospinal fluid in the presence of meningeal inflammation. J Antimicrob Chemother (1985) 0.78
Tetracyclines in the treatment of genitourinary tract infections. Bull N Y Acad Med (1978) 0.78
Nonsurgical ovum transfer as a treatment for intractable infertility: what effectiveness can we realistically expect? Am J Obstet Gynecol (1984) 0.77